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Abstract
Remote ischemic preconditioning (RIPC) is a non-invasive technique in which blood flow is cut off to a
limb for a short period of time which produces a protective effect throughout the whole body to subsequent
low oxygen conditions. One of the prominent cardiovascular limitations to exercise in individuals with
multiple sclerosis (MS) is fatigue, which may stem from the decreased delivery of oxygen to muscle tissue
during exercise. The purpose of this study was to test the hypothesis that RIPC would increase forearm
blood flow (FBF) and utilization of oxygen at the level of the muscle tissue in individuals with MS during
handgrip exercise. FBF and forearm vascular conductance (FVC) were measured using Doppler
Ultrasound technology during rhythmic handgrip exercise both before and after the RIPC intervention, with
muscle oxygen saturation and system hemodynamics measured throughout the protocol. The results of the
present pilot study did not indicate an effect of RIPC on exercise hyperemia; however, due to the small
sample size, further study is worthwhile in order to more accurately determine if RIPC may serve to
increase exercise capacity and quality of life for individuals with MS.
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Introduction
Multiple Sclerosis (MS) is an autoimmune disease affecting approximately 2.3
million people worldwide. It is characterized by demyelination and inflammation of the
central nervous system (CNS) and symptoms vary among individuals depending on the
location of the affected tissue. Currently, the exact etiology is unknown and while there
is currently no cure for MS, treatment options include pharmacology aimed at reducing
specific symptoms and managing relapses and rehabilitation to maintain and restore
function (National Multiple Sclerosis Society). It is well-known that exercise provides
numerous health benefits; however, MS presents several challenges to exercise including
autonomic dysfunction, overheating, and fatigue (Cohen et al., 1989; Bol et al., 2012).
Impairment in autonomic nervous system (ANS) functioning, particularly the
sympathetic nervous system (SNS), in patients with MS has been shown to serve as a
limitation to exercise capacity due to its impact on fatigue. Decreased muscle
sympathetic nerve activity (MSNA) and plasma norepinephrine (NE) concentrations
(Keller et al., 2014) along with reduced forearm blood flow (FBF) (Ranadive et al., 2012;
Huang et al., 2015) in individuals with MS compared to healthy controls suggests
impaired skeletal muscle circulation (Huang et al., 2015). It has been consistently shown
across several studies that patients with MS have a lower arterial blood pressure (BP)
during both isometric and dynamic exercise (Huang et al., 2015), suggesting an impaired
pressor response. Decreased skeletal muscle circulation and attenuated BP responses
would have a negative impact on exercise performance, along with limited muscle
perfusion in patients with MS (Hansen et al., 2013), because less oxygen would be
available to be utilized to produce ATP in aerobic metabolism. Therefore, adequate
blood flow to skeletal muscle is critical to reduce and delay fatigue.
There is evidence to suggest that remote ischemic preconditioning (RIPC) may
benefit exercise performance in skeletal muscle. RIPC involves the application of brief
ischemia to a peripheral tissue, such as a limb, to produce a protective response in other
organs and tissues throughout the body (Przyklenk et al., 1993). While the effects of
RIPC have been most extensively studied on the heart, research suggests that RIPC is
beneficial to improved exercise performance. RIPC has been observed to improve blood
flow and decrease fatigue in skeletal muscle, therefore increasing exercise capacity
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among healthy individuals (Wang et al., 2004; Barbosa et al., 2015). Little research has
been done to date examining the effects of RIPC among individuals with MS. One recent
review examined the mechanistic link between MS and RIPC in the pathophysiology of
ischemic mechanisms and RIPC protection against inflammatory demyelination (CamaraLemarroy et al., 2018). In addition, it has been shown that RIPC offers promising
implications on exercise tolerance among patients with MS based on a feasible doubleblind RCT (Nair et al., 2018).
It is suspected that RIPC will increase exercise hyperemia, the increase in blood
flow that follows a muscle contraction to allow for greater oxygen delivery to skeletal
muscle tissue, in individuals with MS. The purpose of this study is to test the hypothesis
that RIPC will increase blood flow and utilization of oxygen at the level of the muscle
tissue in individuals with MS during handgrip exercise.

Methods
Subjects
Eight volunteers, four healthy controls (35.8 ± 17 years) and four with MS (52.3 ± 7
years), provided written informed consent and underwent screening to determine
eligibility. Inclusion criteria for those with MS included a clinical diagnosis of relapsingremitting MS (RRMS), Expanded Disability Status Scale (EDSS) score between 0 and
4.5, and no relapse within 3 months of the study (Escudero-Uribe et al., 2017) determined
through the volunteers’ self-report. The screening for all participants also included an
assessment for body composition (within normal range according to ACSM guidelines)
via bioelectric impedance (DC-430U, Tanita, Arlington Heights, IL), as well as ensuring
that subjects were non-obese (BMI <25 kg/m2), not hypertensive (resting blood pressure
<140/90 mmHg), mild to moderately active as assessed by subjects’ self-report, not
pregnant, and not currently taking medication with significant cardiovascular effects. MS
patients were allowed to continue their normal regimen, which most often included going
to work and light physical activity throughout the day.
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Rhythmic Handgrip Exercise
Subjects’ maximal voluntary contraction (MVC) was determined by the average of three
maximal squeezes of a handgrip dynamometer that were within 3% of one another. That
average was then used to calculate the relative intensity workload of 10% MVC. A
pulley system was utilized in which the subjects squeezed a handle approximately 3-4 cm
to lift a weight corresponding to their calculated relative workload. The weight was lifted
in a 1:2 sec duty cycle with visual and auditory feedback to ensure correct timing. The
rhythmic handgrip exercise was performed for 4 minutes, with the 4th minute used to
average local and systemic hemodynamics.
System Hemodynamics
Heart rate and beat-to-beat blood pressure were monitored via 3-lead ECG and finger
photoplethysmography, respectively (Nova, Finometer). The finger pressure was
calibrated to a brachial pressure obtained via automatic arm cuff sphygmomanometry.
Forearm Blood Flow (FBF) and Forearm Vascular Conductance (FVC)
FBF and FVC were measured using Doppler Ultrasound technology. A 12-MHz lineararray ultrasound probe (Vivid 8; General Electric, Milwaukee, WI) was utilized to
determine brachial artery mean blood velocity (MBV) and brachial artery diameter. For
blood velocity measurements, the probe insonation angle was maintained at <60° and the
frequency was 5 MHz. Brachial artery diameter measurements were mean in duplex
mode at end-diastole and during steady-state conditions in triplicate. FBF was calculated
as FBF = MBV × π (brachial artery diameter/2)2 × 60 where the FBF is in ml/min, the
MBV is in cm/s, the brachial diameter is in cm, and 60 was used to convert from ml/s to
ml/min. FVC was calculated as FVC = (FBF/MAP) × 100 and is expressed as
ml/min/100 mmHg (Crecelius et al., 2011).
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Muscle Oxygen Saturation (SmO2) and Temperature
SmO2 was measured using near-infrared non-invasive technology (Moxy Monitor, Moxy,
Hutchinson, MN). The device was placed on the skin superficial to the extensor carpi
radialis muscle (palpated during grip) and secured using a lightshield and tape.
Temperature was measured using a probe placed on the skin just proximal to the muscle
oxygenation sensor. Both remained in place the duration of the protocol.
Remote Ischemic Preconditioning
Blood pressure cuffs were wrapped around the subjects’ right thigh, just proximal to the
knee and rapidly inflated to 200 mmHg for 5 minutes of occlusion and deflated for 5
minutes of reperfusion. This procedure was repeated three times (for a total of 4
ischemic bouts) (de Groot et al., 2010).
Experimental Protocol
Prior to the experimental session, the subjects followed a 4-hour fast and a 12-hour
abstention from caffeine, alcohol, and exercise. The study took place in a cool (20-22°C)
environment. After obtaining body composition and MVC measures, the subjects laid in
a supine position with both arms abducted to 90°.
Following 20 minutes of quiet rest and instrumentation, subjects performed the rhythmic
handgrip exercise (Figure 1). In addition, as part of a secondary study/protocol within the
same subjects (Goetz Thesis), after 20 minutes of rest, subjects also performed a measure
of vascular function via reactive hyperemia. Following both measures, the RIPC took
place. The handgrip exercise and reactive hyperemia were both repeated following the
RIPC, with 20 minutes of rest in between each measure.
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Results
System Hemodynamics
As anticipated, HR increased for both control and MS subjects following a period
of handgrip exercise; however, mean HR values were higher in the subjects with MS
compared to the control subjects at all recorded time points. The mean MAP responses
were increased with exercise among all participants with no clear difference between the
two groups. RIPC did not seem to influence MAP values for either group. Mean skin
temperature values remained consistent within the two groups regardless of exercise or
RIPC condition; however, the skin temperature values were lower in subjects with MS
compared to control subjects as expected (Table 2).
Forearm Blood Flow and Forearm Vascular Conductance
During rest, RIPC did not have an effect on FBF (Fig 2a) nor FVC (Fig 3a) as the
changes were slight and inconsistent among subjects. With the exception of an outlier
with significantly higher FBF and FVC values, the subjects with MS had lower FBF and
FVC values compared to the control subjects as expected; however, the response to RIPC
mirrored that of the control subjects. Similarly to rest, during exercise RIPC slightly
increased FBF (Fig 2b) and FVC (Fig 3b) for most subjects while decreasing for others.
Therefore, RIPC does not appear to have had a large effect on either resting nor
exercising FBF or FVC values, and no clear differences were seen between the MS and
control subjects’ responses to RIPC.
Muscle Oxygen Saturation
Resting SmO2 percentages increased following RIPC for most subjects, with the
MS subject’s resting SmO2 percentage increasing the greatest compared to the control
(Fig 4a). RIPC did not appear to effect SmO2 percentages during exercise, as some it
remained relatively unchanged for most subjects (Fig 4b).
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Discussion
The present study focused on the effects of RIPC on exercise capacity within
healthy and MS populations. While the results are preliminary as it is a pilot study, RIPC
did not appear to have a significant effect on exercise hyperemia specifically within the
MS population. RIPC did not elicit greater FBF and FVC increases during exercise in
subjects with MS nor the control subjects as hypothesized. In addition, SmO2 was greater
following the RIPC intervention during rest, with subjects with MS showing a greater
increase compared to the control. This indicates increased O2 supply as well as improved
utilization of O2 at the level of the muscle tissue; however, this increase was not seen
during the exercise portion of the study as was hypothesized. Overall, the results did not
show a strong effect of RIPC on exercise capacity for individuals with MS.
Mechanisms of Remote Ischemic Preconditioning
The exact mechanisms to explain the protective effects of RIPC are still being
investigated; however, both neural and humoral physiological pathways are thought to be
largely influential. It is evident that in order for RIPC to have its beneficial protective
effects on tissues throughout the body the neural pathways must be intact, as observed
when important nerve sections were occluded (femoral nerve and spinal cord) the effects
of RIPC were abolished (Lim et al., 2010; Donato et al., 2013). Specifically regarding
cardiovascular protection, the dorsal motor nucleus of the vagus nerve has been seen to
be important for producing the protective effects of RIPC (Mastitskaya et al., 2012).
There is evidence that there is a strong combination between both the neural and humoral
pathways as RIPC activates the peripheral nerves which then causes a release of
protective humoral factors (Redington et al., 2012; Mastitskaya et al., 2016). The
miRNA-144 effector molecule has been seen to decrease the size of infarction on
occluded tissue and improve the functional recovery time following ischemia suggesting
its major role in the process of RIPC (Hu et al., 2014; Hess et al., 2015). Additionally,
nitric oxide (NO) has been observed to improve perfusion in RIPC (Hess DC, 2016), and
administration of NO prior to preconditioning stimulates the effects of the conditioning
while blocking NO synthesis contrarily inhibits the protective effects (Küntscher et al.,
2002). While the present study did not investigate the specific mechanisms of RIPC, the
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previous findings help to explain the protective effects observed within prior studies and
provide the basis for a clinical application.

Experimental Considerations
Due to the small sample size, the use of statistical analysis on the present findings
was not appropriate to determine significance. Therefore, additional subjects of both the
MS and control groups are needed in order to more accurately generalize the results to a
clinical application. However, the trend of increased oxygen delivery and utilization
within exercising skeletal muscle found within several subjects in this pilot study indicate
that further investigation with a larger sample size would be worthwhile. In addition,
results of previous studies that have found RIPC to help reduce inflammation and
exercise tolerance among individuals with MS (Camara-Lemarroy et al., 2018, Nair et
al., 2018) support the need to further investigate the role of RIPC on the exercise
hyperemia response within this population.
In addition to the small sample size, there were several other limitations to this
present study. The exercise stimulus of a rhythmic handgrip exercise at 10% MVC may
have been too small of a load for the subjects to elicit large cardiovascular changes by the
RIPC intervention. Similarly, while this study only included participants with MS that
were low on the disability scale (EDSS <4.5) for consistency, the low level of impairment
may not have elicited as large of a beneficial effect of the RIPC for those individuals.
Conclusions and Perspectives
Despite the lack of clear significant effects of RIPC within the present study, the
trend of increased exercise hyperemia responses and oxygen utilization following RIPC
of several participants are encouraging that upon further study among a greater
population size, RIPC may serve as a safe and effective method to increase exercise
capacity of individuals with MS. However, while the effects of RIPC on exercise
hyperemia appear promising among the MS population, further research is needed in
order to determine the clinical relevance and the most appropriate use of such an
intervention within the widely diverse range of MS severity and symptoms.
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Figure Legends
Figure 1: Experimental Protocol
Following 20 minutes of quiet rest and instrumentation, subjects performed the rhythmic
handgrip exercise. Resting FBF and SmO2 measurements were taken during the baseline
4 minutes, followed by the exercise measurements taken during the 4 minutes of
rhythmic handgrip exercise. In addition, as part of a secondary study/protocol within the
same subjects (Goetz Thesis), after 20 minutes of rest, subjects also performed a measure
of vascular function via reactive hyperemia. Following both measures, the RIPC took
place in which 5 minutes of occlusion were followed by 5 minutes of perfusion repeated
4 times. The handgrip exercise and reactive hyperemia were both repeated following the
RIPC, with 20 minutes of rest in between each measure.
Figure 2: Forearm Blood Flow
A. FBF values (open circles) are presented at the resting condition for each individual
subject both before and after the RIPC intervention (lines represent the same subject
across time points). The control subjects are represented by a black outline and the
subjects with MS are represented with a red outline.
B. FBF values during the exercise condition are similarly represented for each individual
subject by open circles and connected by lines for each subject before and after the
RIPC intervention. The control subjects are shown by a black outline and the MS
subjects are represented by a red outline.
Figure 3: Forearm Vascular Conductance
A. FVC values (open circles) are presented at rest for each individual subject pre- and
post-RIPC with the lines connecting the individual subject’s data points. Black
outline indicates control subjects and red outline indicates subjects with MS.
B. FVC values during exercise are presented as open circles and connected by lines for
each individual subject, with the black outline indicating control subjects and the red
outline indicating MS subjects.
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Figure 4: Muscle Oxygen Saturation
A. SmO2 percentages are presented during the resting condition for each individual
subject before and after the RIPC intervention, with the open circles indicating the
subjects’ SmO2 value and the lines connecting the same subject’s data across time
points. The black outline indicates control subjects and the red outline indicates MS
subjects.
B. SmO2 percentages are similarly presented during the exercise condition as open
circles with each individual’s data connected by lines both before and after RIPC.
Black outline indicates the control and the red outline indicates the participants with
MS.
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Tables and Figures
Figure 1: Experimental Protocol

Table 1: Subject Characteristics
Control (M=4, F=0)

MS (M=1, F=3)

Age (years)

35.75 ± 17.06

52.3 ± 7.4

Height (cm)

181.08 ± 1.63

165.7 ± 8.4

Weight (kg)

77.94 ± 2.98

62.3 ± 15

BMI (kg/m2)

23.43 ± 0.95

22.7 ± 5.2

Body Fat %

18.075 ± 3.41

27.3 ± 9.5

EDSS

N/A

<4.5

Mean ± standard deviation, M=male, F=female
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Table 2: System Hemodynamics (MAP, HR, Temp)
Pre-RIPC
Rest

Exercise

Rest

Exercise

51 ± 3

59 ± 5

57 ± 3

63 ± 3

91 ± 3

101 ± 4

92 ± 2

93 ± 1

29.4 ± 0.2

29.5 ± 0.1

31.9 ± 1.7

31.2 ± 1.4

HR (bpm)

80 ± 3

86 ± 3

75 ± 3

82 ± 2

MAP (mmHg)

94 ± 4

105 ± 6

89 ± 4

97 ± 10

Temp (°C)

27.1 ± 1.2

27.3 ± 1.3

26.7 ± 0.8

26.6 ± 0.8

HR (bpm)
Control MAP (mmHg)
Temp (°C)
MS

Post-RIPC

Mean ± standard error of means
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Figure 2: Forearm Blood Flow
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Figure 3: Forearm Vascular Conductance
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Figure 4: Muscle Oxygen Saturation
A. Rest
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